Clinical Trial Management System (CTMS) Market Report 2024: Market Size, CAGR

It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%

Aug 14, 2024 - 15:58

0 4

Clinical Trial Management System (CTMS) Market Report 2024: Market Size, CAGR

Overview and Scope
A clinical trial management system (CTMS) is a software platform designed to facilitate and streamline the management of clinical trials. It is a comprehensive solution to centralize, organize, and automate various aspects of the clinical trial process, enabling efficient study planning, execution, monitoring, and reporting.

Sizing and Forecast
The clinical trial management system (ctms) market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to increasing clinical trial complexity, rise in global clinical trials, stringent regulatory compliance, growing focus on patient-centric trials, increasing outsourcing of clinical trials..

The clinical trial management system (ctms) market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to emphasis on real-time data access, integration with electronic health records (ehrs), rise in virtual and decentralized trials, focus on risk-based monitoring, advancements in analytics and ai.. Major trends in the forecast period include focus on regulatory compliance and data security, rise of adaptive clinical trial designs, collaborative platforms for stakeholder engagement, remote site monitoring and management, evolving data standards and interoperability..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/clinical-trial-management-system-ctms-global-market-report

Segmentation & Regional Insights
The clinical trial management system (ctms) market covered in this report is segmented –

1) By System Type: Enterprise Clinical Trial Management System, On-Site Clinical Trial Management System
2) By Component: Software, Service, Hardware
3) By Delivery: Web-based (On-demand), Licensed Enterprise (On-premises), Cloud-based (SaaS)
4) By End User: Large Pharma-biotech Companies, CROs, Medical Device Manufacturers, Small And Mid-sized Pharma-biotech Companies, Other End Users

North America was the largest region in the clinical trial management system (CTMS) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial management system (ctms) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13147&type=smp

Major Driver Impacting Market Growth
The increasing number of decentralized clinical trials is expected to propel the growth of the clinical trial management system (CTMS) market going forward. Decentralized clinical trials (DCTs) refer to studies that utilize telemedicine and local healthcare services to minimize or remove patients' need to visit hospital-based trial locations, in contrast to the traditional clinical trial framework. A clinical trial management system (CTMS) monitors recruitment and participant activities, providing detailed oversight and reporting throughout decentralized trials. For instance, in December 2021, according to Clinical Trials Arena, a UK-based online publication focused on clinical trials and research, the number of trials incorporating decentralized and virtual components is expected to reach approximately 1,300 trials in 2022, with a 28% increase compared to 1000 trials in 2021. Therefore, the increasing number of decentralized clinical trials will drive the growth of the clinical trial management system (CTMS) market.

Key Industry Players
Major companies operating in the clinical trial management system (ctms) market report are The International Business Machines Corporation, Oracle Corporation, Laboratory Corporation of America Holdings, IQVIA Holdings Inc., Wipro Limited, ICON Public Limited Company, PAREXEL International Corporation, Veeva Systems Inc., Bioclinica Inc., Medidata Solutions Inc., Calyx.ai, Clario Medical Imaging Inc., Advarra Inc., Bio-Optronics Inc., MasterControl Inc., ERT Clinical, iWeb Technologies Limited, Anju Software Inc., Axiom Real-Time Metrics, EClinForce Inc., MedNet Solutions Inc., DSG Inc., ArisGlobal LLC, DZS Clinical Services Inc., Datatrak International Inc., Nextrials Nc., SimpleTrials, PHARMASEAL International Limited, Crucial Data Solutions Inc., RealTime Software Solutions LLC

The clinical trial management system (ctms) market report table of contents includes:

1. Executive Summary
2. Clinical Trial Management System (CTMS) Market Characteristics
3. Clinical Trial Management System (CTMS) Market Trends And Strategies
4. Clinical Trial Management System (CTMS) Market - Macro Economic Scenario
.
.
.
5. Global Clinical Trial Management System (CTMS) Market Size and Growth
32. Global Clinical Trial Management System (CTMS) Market Competitive Benchmarking
33. Global Clinical Trial Management System (CTMS) Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Clinical Trial Management System (CTMS) Market
35. Clinical Trial Management System (CTMS) Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info